Biotech Growth Trust plc (The) (BIOG) Ordinary 25p

- Add to watchlist
- Create an alert
- This stock can be held in a




757.00p
758.20p
979.00p
821.58
758.00p
741.76p
715.00p
-8.35%
5.00p (0.66%) Previous:
5.00p
28,208
n/a
GBX
Price
-
Net Asset Value (NAV)

Performance
1 week 1W | 0.26% | 1 year 1Y | 19.28% |
---|---|---|---|
1 month 1M | 3.84% | 2 years 2Y | 37.25% |
3 months 3M | 3.68% | 3 years 3Y | 47.87% |
6 months 6M | 8.23% | 5 years 5Y | 8.6% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | NASDAQ Biotechnology TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | Yes |
Ongoing charge: | 1.30% |
Dividend yield: | n/a |
Dividend frequency: | None |
Total assets: | £298m |
Gross gearing: | 2% |
Market capitalisation:Market cap.: | £267m |
Shares in issue: | 34.98 million |
Legal structure | Closed Ended Investment Company |
Domicile: | United Kingdom |
ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 821.58 |
---|---|
Latest actual NAV: | 819.12 |
Latest actual NAV date: | 24 November 2023 |
Premium/Discount: | -8.35% |
12m average Premium/Discount: | -7.99% |
NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Security | Weight |
---|---|
Amgen Inc | 7.13% |
Biogen Inc | 6.53% |
Argen X SE EUR0.10 | 5.26% |
Biomarin Pharmaceutical Inc | 5.21% |
Syndax Pharmaceuticals Inc | 4.90% |
Ionis Pharmaceuticals Inc | 4.62% |
Vera Therapeutics Inc Class A | 4.42% |
Xtalpi | 3.99% |
Travere Therapeutics Inc Ordinary Shares | 3.53% |
United Therapeutics Corp | 3.42% |
Sector | Weight |
---|---|
Healthcare | 98.65% |
Country | Weight |
---|---|
United States | 90.70% |
China | 4.09% |
Canada | 3.97% |
Netherlands | 1.53% |
Germany | 1.47% |
Switzerland | 0.73% |
Denmark | 0.15% |
Key Dates
Launch date: | 23 June 1997 |
---|---|
Financial year end: | March |
Next AGM: | July 2024 |

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.